HSF-6, UC06
UCSFe002-A
General
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | |
Ethics
| How may genetic information associated with the cell line be accessed? |
hESC Derivation
iPSC Culture Conditions
| Passage method | Enzymatically | ||||||
| Medium |
Other medium:
Base medium: Knockout-DMEM
Main protein source: Knock-out serum replacement Serum concentration: 20 % Supplements
|
iPSC Characterisation
Analysis of undifferentiated iPSCs
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| SSEA-3 |
Yes |
|
||||
| SSEA-4 |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
||||
| nodal |
Yes |
|
||||
| LEFTYA |
Yes |
|
||||
| EPHA2 |
Yes |
|
||||
| ZFP42 (REX-1) |
Yes |
|
||||
| SOX2 |
Yes |
|
||||
| THY1 (CD90) |
Yes |
|
Genotyping
Karyotyping (iPSC Line) |
|
| Has the iPSC line karyotype been analysed? |
Yes
46XX
Passage number: 43
|
Other Genotyping (iPSC Line) |
|
Login to share your feedback, experiences or results with the research community.